Evidence map›Paper›PMID 39113550›Full record

ArticleOrganic & biomolecular chemistry2024

Chloroformate-mediated ring cleavage of indole alkaloids leads to re-engineered antiplasmodial agents.

Daniel C Schultz, Alejandra Chávez-Riveros, Michael G Goertzen, Beau R Brummel, Raphaella A Paes, Natalia M Santos, Srinivasarao Tenneti, Khalil A Abboud, James R Rocca, Gustavo Seabra and 3 more

Abstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniel C SchultzDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.ORCID 0000-0002-7727-9148
Alejandra Chávez-RiverosDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Michael G GoertzenDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Beau R BrummelDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Raphaella A PaesDivision of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, USA.ORCID 0000-0002-6146-5309
Natalia M SantosDivision of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, USA.
Srinivasarao TennetiDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Khalil A AbboudDepartment of Chemistry, University of Florida, Gainesville, Florida 32610, USA.
James R RoccaDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Gustavo SeabraDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Chenglong LiDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.
Debopam ChakrabartiDivision of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, USA.
Robert W HuigensDepartment of Medicinal Chemistry, Center for Natural Product Drug Discovery & Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA. rhuigens@cop.ufl.edu.ORCID 0000-0003-3811-2721

Funding

Comprehensive Training Program in Oral BiologyT90DE021990 · NIDCR · UNIVERSITY OF FLORIDA · PI Jose A Lemos · 2011 to 2026
$8.2M
Role and targeting of PRMT5 in prostate cancerR01CA212403 · NCI · PURDUE UNIVERSITY · PI HUANG, JIAOTI, LI, CHENGLONG · 2017 to 2021
$3.0M
Indole Alkaloids and Phenazine Antibiotics: New Platforms for Drug DiscoveryR35GM128621 · NIGMS · UNIVERSITY OF FLORIDA · PI HUIGENS, ROBERT WILLIAM · 2018 to 2022
$1.7M
Chemistry-Biology Interface Training Program at the University of FloridaT32GM136583 · NIGMS · UNIVERSITY OF FLORIDA · PI Chenglong Li · 2020 to 2026
$1.1M
NMR console upgrade for structural biology and metabolomicsS10OD028753 · OD · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2020 to 2020
$600k
Acquisition of a Q Exactive HF Hybrid Quadrupole-OrbitrapS10OD021758 · OD · UNIVERSITY OF FLORIDA · PI BASSO, KARI B · 2017 to 2017
$600k
National Science Foundation CHE-1828064National Science Foundation DMR-1644779NCI NIH HHS R01 CA212403NIDCR NIH HHS T90 DE021990NIGMS NIH HHS R35 GM128621NIGMS NIH HHS T32 GM136583NIH HHS S10 OD021758NIH HHS S10 OD028753
6 · The paper itself

Abstract

Natural product ring distortion strategies have enabled rapid access to unique libraries of stereochemically complex compounds to explore new chemical space and increase our understanding of biological processes related to human disease. Herein is described the development of a ring-cleavage strategy using the indole alkaloids yohimbine, apovincamine, vinburnine, and reserpine that were reacted with a diversity of chloroformates paired with various alcohol/thiol nucleophiles to enable the rapid synthesis of 47 novel small molecules. Ring cleavage reactions of yohimbine and reserpine produced two diastereomeric products in moderate to excellent yields, whereas apovincamine and vinburnine produced a single diastereomeric product in significantly lower yields. Free energy calculations indicated that diastereoselectivity regarding select ring cleavage reactions from yohimbine and apovincamine is dictated by the geometry and three-dimensional structure of reactive cationic intermediates. These compounds were screened for antiplasmodial activity due to the need for novel antimalarial agents. Reserpine derivative 41 was found to exhibit interesting antiplasmodial activities against

Indexed as

AntimalarialsIndole AlkaloidsPlasmodium falciparumFormatesHumansMolecular StructureParasitic Sensitivity TestsStereoisomerismAntimalarialsFormatesIndole Alkaloids

Identifiers

PMID39113550
PMCPMC11913174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.